70 related articles for article (PubMed ID: 58978)
1. [A transferable "myasthenogenic" factor in the serum of patients with myasthenia gravis (author's transl)].
Toyka KV; Drachman DB; Pestronk A; Fischbeck H; Kao I
J Neurol; 1976 Jun; 212(3):271-80. PubMed ID: 58978
[TBL] [Abstract][Full Text] [Related]
2. [A transferable "Myasthenogenic" factor in the serum of patients with myasthenia gravis.].
Toyka KV; Drachman DB; Pestronk A; Fischbeck KH; Kao I
J Neurol; 1976 Jun; 212(3):271-80. PubMed ID: 20563776
[TBL] [Abstract][Full Text] [Related]
3. Myasthenia gravis. Study of humoral immune mechanisms by passive transfer to mice.
Toyka KV; Drachman DB; Griffin DE; Pestronk A; Winkelstein JA; Fishbeck KH; Kao I
N Engl J Med; 1977 Jan; 296(3):125-31. PubMed ID: 831074
[TBL] [Abstract][Full Text] [Related]
4. Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice.
Klooster R; Plomp JJ; Huijbers MG; Niks EH; Straasheijm KR; Detmers FJ; Hermans PW; Sleijpen K; Verrips A; Losen M; Martinez-Martinez P; De Baets MH; van der Maarel SM; Verschuuren JJ
Brain; 2012 Apr; 135(Pt 4):1081-101. PubMed ID: 22396395
[TBL] [Abstract][Full Text] [Related]
5. Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction.
Cole RN; Reddel SW; Gervásio OL; Phillips WD
Ann Neurol; 2008 Jun; 63(6):782-9. PubMed ID: 18384168
[TBL] [Abstract][Full Text] [Related]
6. Electrophysiological effects of myasthenic serum factors studied in mouse muscle.
Lerrick AJ; Wray D; Vincent A; Newsom-Davis J
Ann Neurol; 1983 Feb; 13(2):186-91. PubMed ID: 6830177
[TBL] [Abstract][Full Text] [Related]
7. Passive transfer of seronegative myasthenia gravis to mice.
Burges J; Vincent A; Molenaar PC; Newsom-Davis J; Peers C; Wray D
Muscle Nerve; 1994 Dec; 17(12):1393-400. PubMed ID: 7969240
[TBL] [Abstract][Full Text] [Related]
8. A myasthenia gravis plasma immunoglobulin reduces miniature endplate potentials at human endplates in vitro.
Burges J; Wray DW; Pizzighella S; Hall Z; Vincent A
Muscle Nerve; 1990 May; 13(5):407-13. PubMed ID: 2345558
[TBL] [Abstract][Full Text] [Related]
9. Myasthenia induced by monoclonal anti-acetylcholine receptor antibodies: clinical and electrophysiological aspects.
Burres SA; Crayton JW; Gomez CM; Richman DP
Ann Neurol; 1981 Jun; 9(6):563-8. PubMed ID: 6167199
[TBL] [Abstract][Full Text] [Related]
10. Acetylcholine release in diaphragm of rats with chronic experimental autoimmune myasthenia gravis.
Kelly JJ; Lambert EH; Lennon VA
Ann Neurol; 1978 Jul; 4(1):67-72. PubMed ID: 211931
[TBL] [Abstract][Full Text] [Related]
11. Myasthenia gravis: passive transfer from man to mouse.
Toyka KV; Brachman DB; Pestronk A; Kao I
Science; 1975 Oct; 190(4212):397-9. PubMed ID: 1179220
[TBL] [Abstract][Full Text] [Related]
12. Experimental autoimmune myasthenia gravis: the rabbit as an animal model.
Eldefrawi ME
Fed Proc; 1978 Dec; 37(14):2823-7. PubMed ID: 720635
[TBL] [Abstract][Full Text] [Related]
13. A modified assay for antibody against the nicotinic acetylcholine receptor in myasthenia gravis.
Dwyer DS; Bradley RJ; Oh SJ; Kemp GE
Clin Exp Immunol; 1979 Sep; 37(3):448-51. PubMed ID: 509779
[TBL] [Abstract][Full Text] [Related]
14. [Observation on the changes in the frequency of end-plate potentials evoked by sera with different antibodies from patients with myasthenia gravis in nerve-muscle preparation of rats].
Lu C
Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1992 Feb; 25(1):44-6, 63. PubMed ID: 1317284
[TBL] [Abstract][Full Text] [Related]
15. Passive transfer of the Lambert-Eaton myasthenic syndrome: neuromuscular transmission in mice injected with plasma.
Kim YI
Muscle Nerve; 1985 Feb; 8(2):162-72. PubMed ID: 2997605
[TBL] [Abstract][Full Text] [Related]
16. [Myasthenia gravis with electrophysiological features of Lambert-Eaton myasthenic syndrome: usefulness of serum autoantibodies assay and neuromuscular junction biopsy].
Matsumoto R; Motomura M; Yoshimura T; Kohara N; Kato T
Rinsho Shinkeigaku; 1999 May; 39(5):531-7. PubMed ID: 10424144
[TBL] [Abstract][Full Text] [Related]
17. [The evidence of antibodies against motor endplates of the skeletal muscle in myasthenia gravis with the double immune-fluorescence technique (author's transl)].
Storch W; Trautmann B
Acta Histochem; 1981; 69(1):18-22. PubMed ID: 6795885
[TBL] [Abstract][Full Text] [Related]
18. Myasthenia gravis. Current concepts.
Gutmann L; Chou SM
Arch Pathol Lab Med; 1976 Aug; 100(8):401-4. PubMed ID: 947303
[TBL] [Abstract][Full Text] [Related]
19. Congenital canine myasthenia gravis: I. Deficient junctional acetylcholine receptors.
Oda K; Lambert EH; Lennon VA; Palmer AC
Muscle Nerve; 1984; 7(9):705-16. PubMed ID: 6543919
[TBL] [Abstract][Full Text] [Related]
20. Critical reexamination of the thymus immunization model of myasthenia gravis.
Murphy A; Drachman DB; Satya-Murti S; Pestronk A; Eggleston JC
Muscle Nerve; 1980; 3(4):293-7. PubMed ID: 7412773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
